Skip to content

INTERCEPT Processing Set for Small Volume (SV) Platelet Units

by Cerus Corporation

Ref INT21, INT2103B

Active European Union

CE MDR

Valid until

2 Mar 2028

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier TÜV SÜD Product Service GmbH

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number872058919007PLT2L Basic UDI-DI 18717953197020UDI-DIDate6 Oct 2025RegisteredStatusActive

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • G70 104609 0007 Active Amended

    Technical documentation EU MDR

    Issued
    31 Jul 2025
    Expires
    2 Mar 2028
    Reason
    Other

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
INTERCEPT Processing Set for Platelets
Model / Reference
INT21, INT2103B
Primary DI / UDI-DI
18717953197020
Basic UDI-DI
872058919007PLT2L
EMDN Code
B010199 Blood collection bags and kits - other
Device Class
Class III
EU market of registration
Austria

Manufacturer details

EUDAMED SRN
US-MF-000000765
Authorised representative
Cerus Europe B.V. NL-AR-000000115

Other devices from Cerus Corporation

See all devices from Cerus Corporation →

Properties

  • Sterile
  • Endocrine Disruptor

Other properties (11)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No